Dr. Paula Bryant

Dr. Paula Bryant is the Director of the Office of Biodefense, Research Resources, and Translational Resources, and the Associate Director for Biodefense and Emerging Infectious Diseases Product Development at NIH’s National Institute of Allergy and Infectious diseases (NIAID). In these roles, she oversees the late preclinical and early clinical development of vaccines, therapeutics and diagnostics for NIAID priority pathogens. Dr. Bryant joined NIAID in 2013 as a Senior Scientific Officer dedicated to vaccine concept acceleration, where she was responsible for identifying and shepherding innovative vaccine concepts and technologies into viable product development pathways. Before joining NIAID, Dr. Bryant served as the Chief of the Translational Medical Division of the Defense Threat Reduction Agency's (DTRA) Chemical and Biological Technologies Directorate, the Joint Science Technology Organization (JSTO). Prior to government service, Dr. Bryant was an Assistant Professor in the Department of Microbiology at The Ohio State University where she established a research program examining the interaction of intracellular pathogens with the class II MHC antigen processing and presentation pathway. Dr. Bryant received a Ph.D. in Microbiology and Immunology from Baylor College of Medicine. She conducted post-doctoral research at the Massachusetts Institute of Technology and Harvard Medical School as an Irvington Institute for Immunological Research Fellow.